Brian Halak
SlowingNamed in filings at Domain PartnersOn the current fund
- Board seats filed
- 7
- Named on a board
- 1
all filings on record
Named in filings at Domain PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| ThirdLaw Molecular | Biotech & pharma | September 2025 | None on file |
| SonoThera | Biotech & pharma | April 2022 | ARCH Venture Partners, Vida Ventures |
| WindMIL Therapeutics | Biotech & pharma | March 2016 | Qiming U.S Healthcare |
| Kona Medical | Medical devices | August 2015 | Lightstone Ventures, Qiming U.S Healthcare |
| ORAYA THERAPEUTICS | Medical devices | April 2014 | None on file |
| ALIMERA SCIENCES | Biotech & pharma | January 2014 | Sofinnova Healthquest Partners |
| BioNano Genomics | Biotech & pharma | December 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Brian Halak on the board, based on 7 filed seats with a verified or cited source.